Companies in
Pharmaceutical Industry

Protaccine Biotec Sàrl

Pharmaceutical Industry · Delémont · Since 2017

The core activity of Protaccine Biotec Sarl is the development and production of high-quality anti-snake venom sera, other antiserum-based products, thermostable vaccines and biological products based on new technologies at affordable prices. Additionally, the company offers consulting services and turnkey solutions for the vaccine and biotechnology industry, and supports patients in various treatments, including cancer treatments through immunotherapy and gene therapy.

Protochemie AG

Pharmaceutical Industry · Mitlödi · Since 1949

Protzek Biotec GmbH

Medical Technology Industry · Reinach Bl · Since 2003

The core activity of Protzek is the development, production and distribution of objective test and analysis systems for medical, police and forensic applications, particularly in the fields of toxicology and virology, with a focus on sustainable and environmentally friendly products.

PROVECTIS HEALTHCARE AG

Pharmaceutical Industry · Basel · Since 2024

The core activity of Provectis Healthcare AG is the development, manufacture and marketing of health products, particularly in the field of nutraceuticals and dermaceuticals. The company focuses on partnering with innovative biopharma companies to establish their products on the market and provide patients worldwide with access to these solutions. Provectis supports its partners in product development, market launch and marketing to maximize the success of their products.

Pure Pharma AG

Pharmaceutical Industry · Laufenburg · Since 2024

The core activity of Pure Holding AG is the breeding, cultivation, processing and distribution of cannabis products. The company focuses on improving the safety and quality of cannabis products and offers a wide range of products, from seeds to finished products.

Qanatpharma AG

Pharmaceutical Industry · Stans · Since 2023

The core activity of Qanatpharma is the development of new therapeutic strategies for the treatment of diseases caused by microvascular dysfunction. The company is particularly focused on researching and developing medications that improve microvascular function and alleviate the effects of diseases such as cognitive decline, hypertension, and heart failure.

Quercis Pharma AG

Pharmaceutical Industry · Zug · Since 2024

The core activity of Quercis Pharma AG is the development of pharmaceuticals, particularly the research and development of medications for the prevention of thrombosis and other diseases, such as cancer and neurological disorders. The company focuses on the development of Isoquercetin-based medications, such as Kinisoquin, and conducts clinical trials to test their efficacy and safety.

Rapid Pharma Development GmbH

Research & Development · Unterägeri · Since 2007

The core activity of Rapid Pharma Development GmbH is the provision of services for the development of pharmaceutical projects, particularly in the areas of: project management, CMC (Chemistry, Manufacturing and Controls), GMP auditing, regulatory consulting, development of active pharmaceutical ingredients (API) and formulations, analytical activities, and outsourcing management of pharmaceutical development projects. The company supports its customers in the development of medicinal products, from the early phase to market authorization, and offers a wide range of services to accelerate and optimize the development of pharmaceutical projects.

RDP Pharma AG

Pharmaceutical Industry · Romanshorn · Since 2023

RDP Pharma AG is a privately held biotech company focused on drug discovery and development of therapeutic and delivery technologies, notably the PromptDegrader™ platform for targeted degradation of intrinsically disordered region (IDR) proteins. Its pipeline includes an orally available HPV E7 degrader and additional projects such as CROMOC (drug delivery module) and CP201 (an oral alkyletherlipid candidate for cancer treatment).

RDP PROMPT AG

Pharmaceutical Industry · Romanshorn · Since 2022

RDP PROMPT AG is a privately held biotech company developing therapeutics that identify and degrade intrinsically disordered region (IDR) proteins using the PromptDegrader™ protein modulation platform. Its projects include an E7 degrader targeting the HPV E7 oncoprotein, research on MYC, and other programs such as CROMOC and CP201.

Redbiotec AG

Research & Development · Schlieren · Since 2006

The core activity of Redbiotec AG is the development and production of key proteins and genetic materials for the biopharmaceutical and food industries. The company focuses on the research and development of therapeutic bacteria for the treatment of cancer and genetic diseases.

Refarmed Chemicals SA

Chemical Industry · Lugano · Since 1995

The core activity of Refarmed Chemicals Ltd. is the distribution of pharmaceutical active ingredients (Active Pharmaceutical Ingredients, API) and finished dosage forms (Finished Dosage Form, FDF) for the generic pharmaceutical industry.

Regeneron Switzerland GmbH

Research & Development · Basel · Since 2023

Regeneron Switzerland GmbH is a biopharmaceutical company that researches, develops, and commercializes medicines, including biologics and genetic medicines. It conducts clinical trials and maintains research and manufacturing activities to support its drug development pipeline.

Relief Therapeutics International SA

Pharmaceutical Industry · Geneva · Since 2018

Renaldee AG

Pharmaceutical Industry · Augst Bl · Since 2021

The core activity of Renaldee is the development and marketing of a natural, active vitamin D product for patients with chronic diseases, particularly those with chronic kidney disease (CKD).

Repertoire Immune Medicines (Switzerland) AG

Research & Development · Schlieren · Since 2018

The core activity of Repertoire Immune Medicines is the development of innovative immunotherapies for various therapeutic areas, particularly for cancer, autoimmune diseases, and infectious diseases. The company utilizes its proprietary DECODE platform to decipher the unique immune codes of the human body and develop medicines that can program the immune system to selectively eliminate tumors or restore balance to the immune system in autoimmune diseases.

ReproNovo SA

Pharmaceutical Industry · Lausanne · Since 2021

The core activity of ReproNovo is the development of innovative solutions for reproductive medicine and women's health, particularly the treatment of infertility and adenomyosis. The company focuses on developing therapeutic approaches to improve the success rates of assisted reproductive technologies and to develop new treatment options for men with hypogonadism and women with adenomyosis.

Respira AG

Pharmaceutical Industry · Hochdorf · Since 2017

Respira AG develops, manufactures and markets medical devices, food supplements and cosmetics internationally. Its product range includes nasal sprays, wound‑healing products and formulations for digestive comfort, immunity and sleep; products are dermatologically tested, formulated with hypoallergenic ingredients and produced under certifications such as GMP+ and Cosmébio. The company is part of the Pharmalys group and has expertise in infant health.

Rheinbrands GmbH

Cosmetics Industry · Basel · Since 2011

The core activity of RheinBrands GmbH is the development and distribution of innovative consumer healthcare products, particularly in the area of intimate care and wellness products, condoms, medical lubricants and other products for a healthy, clean and hygienic intimate area.

Rhenochem AG

Pharmaceutical Industry · Basel · Since 1990

Rhenochem AG is a pharmaceutical company offering distribution and sourcing of active pharmaceutical ingredients and finished formulations, together with contract manufacturing and technology transfer. Its services include regulatory support, pharmaceutical logistics, financing assistance and market intelligence.

Rhenopharma AG

Pharmaceutical Industry · Basel · Since 2008

The company's core activity is the development, production, packaging and distribution of pharmaceutical products and services, particularly in the field of healthcare. The company offers integrated, customized services and solutions for the pharmaceutical industry, including "Supply Chain as a Service", to increase efficiency, profitability and patient care on a global scale.

Rhizen Pharmaceuticals AG

Pharmaceutical Industry · Basel · Since 2008

The core activity of Rhizen Pharmaceuticals AG is the development and marketing of pharmaceuticals, particularly in the field of oncology (cancer treatment) and onco-supportive care. The company focuses on the discovery, development and commercialization of innovative pharmaceuticals that address multiple cancer indications. It has a deep pipeline of assets covering various oncology indications and has expertise in discovery, preclinical development, clinical development and regulatory affairs.

RIDGELINE Discovery GmbH

Research & Development · Basel · Since 2020

RIDGELINE Discovery GmbH creates and operates Versant‑financed biotechnology companies and develops the underlying science and technologies for new ventures. The organization conducts early‑stage drug discovery, develops platforms and therapeutic candidates, and partners with entrepreneurs, industry and academic groups.

Rivopharm SA

Pharmaceutical Industry · Manno · Since 1961

The core activity of Rivopharm is the development, manufacture and marketing of pharmaceutical products, including generic and branded medicines, dietary supplements and other health products. The company also provides services such as product formulation, packaging and regulatory affairs, and operates in more than 60 countries worldwide.

Roche Chemische Unternehmungen AG

Pharmaceutical Industry · Basel · Since 1958

Roche Diagnostics International AG

Pharmaceutical Industry · Rotkreuz · Since 1998

Roche Diagnostics International AG develops and supplies diagnostic systems and tests for hospitals, laboratories and medical practices. The organization integrates research and development, production, marketing and service functions to create instruments, fully automated in‑vitro diagnostic systems and digital solutions.

Roche Glycart AG

Pharmaceutical Industry · Schlieren · Since 2000

Roche International AG

Pharmaceutical Industry · Basel · Since 2024

Roche Sapac AG

Pharmaceutical Industry · Basel · Since 2022

Rocketvax AG

Pharmaceutical Industry · Basel · Since 2019

The core activity of RocketVax AG is the development and research of vaccines, particularly against Covid-19. The company focuses on developing vaccines that guarantee better immunity and can be easily administered through the nose. It is also working on improving Corona vaccine protection and plans to develop new vaccines.

RUBIMED AG

Pharmaceutical Industry · Hergiswil Nw · Since 1998

The core activity of Rubimed AG is the development, dissemination and support of Psychosomatic Energetics (PSE), an alternative medical method that focuses on the treatment of diseases and complaints through the combination of scientific knowledge, psychology, homeopathy and Far Eastern energy doctrine. The company provides information, materials and support for therapists and patients who apply or wish to apply this method.

RXcel GmbH

Research & Development · Basel · Since 2023

RXcel GmbH develops RNA-based therapeutics for oncology that use engineered RNA molecules to detect cancer cells by the absence of specific genetic markers and to trigger selective therapeutic effectors. The company focuses on conditional-stability RNA designs targeting glioblastoma and reports in vitro/preclinical data alongside academic collaborations on its website.

Boehringer Ingelheim Veterinary Medicine Switzerland AG

Pharmaceutical Industry · Zurich · Since 2024

Saiba X AG

Pharmaceutical Industry · Pfäffikon Sz · Since 2024

Salmon Pharma GmbH

Pharmaceutical Industry · Basel · Since 1982

The company's core activity is the development, production and distribution of pharmaceuticals, particularly in the areas of ADHD, anemia, nephrology and urology. The company specializes in the manufacture of medications that aim to improve the quality of life for patients.

Salus Schweiz AG

Pharmaceutical Industry · Pfäffikon Sz · Since 2024

The core activity of Salus Schweiz AG is the development, manufacture and distribution of health products, in particular tonics, teas, elixirs, tablets and other plant-based products.

SANOFI GESTION SA

Pharmaceutical Industry · Vernier · Since 1993

SANOFI GESTION SA is a healthcare and pharmaceutical company supplying therapeutic solutions, vaccines and health products. Its activities include immunology, rare diseases, oncology, neurology, general medicines and consumer health.

Santen SA

Medical Technology Industry · Geneva · Since 2014

The company's core activity is the development, manufacture and marketing of pharmaceutical products in the field of ophthalmology, with the aim of developing innovative and effective solutions for the treatment of eye diseases and providing added value to patients and society.

Santhera GmbH

Pharmaceutical Industry · Buchs Sg 3 · Since 2001

The core activity of Santhera Pharmaceuticals is the development and marketing of therapeutic solutions for rare and life-threatening diseases. The company focuses on researching and developing medications to improve the lives of patients with these diseases.

Sarepta International Holdings GmbH

Research & Development · Zug · Since 2017

The core activity of Sarepta Therapeutics is the development and manufacturing of gene therapies for the treatment of rare diseases, particularly muscular dystrophies such as Duchenne muscular dystrophy, limb-girdle muscular dystrophy (LGMD), and Charcot-Marie-Tooth disease. The company focuses on researching and developing precision gene medicine and aims to increase efficiency in drug development and shorten the time from laboratory to patient.

saverna therapeutics AG

Pharmaceutical Industry · Biel-Benken Bl · Since 2017

The core activity of Saverna Therapeutics is the discovery and development of small, orally active molecules targeting non-coding RNA biology to treat diseases with unmet medical needs. The company utilizes a platform based on artificial intelligence and nuclear magnetic resonance to reduce the time and cost of drug development.

Scalepharm AG

Research & Development · Baar · Since 2019

The core activity of Scalepharm is the development, registration, manufacture and marketing of generic finished medicinal products, in particular prescription-only medicines, which are distributed through retail pharmacies and hospitals.

Schülke & Mayr AG

Chemical Industry · Frauenfeld · Since 1994

The core business of Schülke & Mayr GmbH is the development, manufacture and marketing of products and solutions for infection prevention, hygiene and preservation, particularly in the healthcare sector.

Schwabe Pharma AG

Pharmaceutical Industry · Küssnacht Am Rigi · Since 1992

The company's core activity is the production and distribution of homeopathic and herbal remedies.

Schweizer Blisterzentrum AG

Packaging Industry · Zurich · Since 1986

The Swiss Blister Centre is a company specializing in the blister packaging of medications. The core activity of the company is to manufacture individually portioned medications for patients to increase safety when taking medications. The company offers a modern production facility where medications are packaged to enable patients to receive safe and individualized medication administration.

Seegpharm SA

Pharmaceutical Industry · Lugano · Since 2012

Seegpharm SA develops and out-licenses complex generic pharmaceuticals through product co‑development. The company outsources development work including API synthesis‑route development and finished‑dosage‑form development, manages patent freedom‑to‑operate analyses and regulatory registrations, and undertakes selected promotion and distribution activities.

Seito Biologics AG

Research & Development · Küsnacht Zh · Since 2023

The core activity of SEITO Biologics is the development of innovative, targeted immunotherapies, in particular selective Treg cell engagers (TREX), aiming to restore balance to the immune system in patients with autoimmune and inflammatory diseases.